Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_assertion type Assertion NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_head.
- NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_assertion description "[Using immunohistochemistry, a score including PAK1 and co-expression of PKA and ER?S305-P (PKA/ER?S305-P) was developed on a training set consisting of 103 patients treated with tamoxifen for metastatic disease, and validated on 231 patients randomized between adjuvant tamoxifen or no treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_provenance.
- NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_assertion evidence source_evidence_literature NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_provenance.
- NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_assertion SIO_000772 20213082 NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_provenance.
- NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_assertion wasDerivedFrom befree-2016 NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_provenance.
- NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_assertion wasGeneratedBy ECO_0000203 NP798590.RAYArXCBT3sbprhhu_Yaqa2VcmqvUKSnw2SPzd3mcHTqM130_provenance.